Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Danimer Scientific Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Danimer Scientific's earnings have been declining at an average annual rate of -45.7%, while the Chemicals industry saw earnings growing at 12.5% annually. Revenues have been declining at an average rate of 9.1% per year.
Anahtar bilgiler
-45.7%
Kazanç büyüme oranı
-27.2%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 12.9% |
| Gelir büyüme oranı | -9.1% |
| Özkaynak getirisi | -55.3% |
| Net Marj | -325.9% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts
May 21
Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 10Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher
Apr 25Danimer Scientific Is In Trouble
Nov 17Danimer Scientific: It's Not Time To Buy
Sep 05Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream
Jun 20Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)
May 15Danimer Scientific: Falling Momentum As Cash Burn Climbs
Dec 19What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates
Nov 17Danimer Scientific: Biodegradable Plastics Are Still Important
Sep 30Danimer Scientific stock slides on $100M securities offering
Aug 26These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat
Aug 17Danimer Scientific: Bright Future But Currently A Murky Investment Case
Jun 07Gelir ve Gider Dağılımı
Danimer Scientific nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 40 | -130 | 51 | 24 |
| 31 Mar 24 | 45 | -146 | 61 | 26 |
| 31 Dec 23 | 47 | -155 | 73 | 28 |
| 30 Sep 23 | 51 | -144 | 75 | 28 |
| 30 Jun 23 | 51 | -199 | 77 | 30 |
| 31 Mar 23 | 50 | -190 | 81 | 31 |
| 31 Dec 22 | 53 | -180 | 85 | 31 |
| 30 Sep 22 | 56 | -164 | 89 | 33 |
| 30 Jun 22 | 59 | -61 | 97 | 29 |
| 31 Mar 22 | 60 | 8 | 94 | 25 |
| 31 Dec 21 | 59 | -60 | 82 | 20 |
| 30 Sep 21 | 53 | -51 | 64 | 14 |
| 30 Jun 21 | 53 | -61 | 41 | 10 |
| 31 Mar 21 | 50 | -102 | 24 | 9 |
| 31 Dec 20 | 47 | -9 | 17 | 7 |
| 30 Sep 20 | 44 | -9 | 15 | 7 |
| 30 Jun 20 | 40 | -3 | 14 | 6 |
| 31 Mar 20 | 35 | -11 | 15 | 5 |
| 31 Dec 19 | 32 | -20 | 17 | 5 |
| 31 Dec 18 | 30 | 0 | 7 | 5 |
Kaliteli Kazançlar: DNMR is currently unprofitable.
Büyüyen Kar Marjı: DNMR şu anda kârlı değil.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: DNMR kârlı değil ve zararlar son 5 yılda yılda 51.4% oranında arttı.
Büyüme Hızlandırma: Unable to compare DNMR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: DNMR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.8%).
Özkaynak Getirisi
Yüksek ROE: DNMR has a negative Return on Equity (-55.34%), as it is currently unprofitable.